San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech ...

referring to inversions and breakpoints that would be missed using comparative genome hybridization and fosmid paired-end sequencing. John West, general manager of Illumina's DNA sequencing ...

“This is the same instrument the scientific community has come to rely on for next-generation sequencing, now with upgraded software, new kits, and the option for a lower volume,” Illumina’s ...

SAN DIEGO, Jan. 13, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology ...

By the end of April, more than 12,000 SARS ... distinguished scientist and VP at Illumina. “A next-generation sequencing (NGS) system to back up the PCR is really important to ensure that ...

Illumina and Regeneron are taking stakes in ... of Health’s All of Us million-person program and other massive DNA sequencing projects. The companies—supported by more than a dozen major ...

Following the Jan. 13 announcement, Illumina shares jumped 5.5% to close at $144.22 on Monday. The company has democratized sequencing over the past 20 years, and with the progress in AI and ...